Land: Ástralía
Tungumál: enska
Heimild: Department of Health (Therapeutic Goods Administration)
eslicarbazepine acetate, Quantity: 800 mg
Maxx Pharma Pty Ltd
Tablet, uncoated
Excipient Ingredients: magnesium stearate; croscarmellose sodium; povidone
Oral
60 tablets, 30 tablets, 90 tablets, 180 tablets, 20 tablets
(S4) Prescription Only Medicine
ZEBINIX is indicated as:,? monotherapy in the treatment of partial-onset seizures, with or without secondary generalisation, in adults with newly diagnosed epilepsy;,? adjunctive therapy in adults, adolescents and children aged above 6 years, with partial-onset seizures with or without secondary generalisation.
Visual Identification: ZEBINIX 800 mg tablets are white oblong tablets, engraved with ESL 800 on one side and scored on the other side; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 5 Years; Container Temperature: Store below 30 degrees Celsius
Registered
2021-05-18
ZEBINIX® 200 mg and 800 mg tablets 1 ZEBINIX® CONSUMER MEDICINE INFORMATION (CMI) SUMMARY The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. This medicine is new. Please report side effects. See the full CMI for further details. 1. WHY AM I USING ZEBINIX? ZEBINIX contains the active ingredient eslicarbazepine acetate (ESL). ZEBINIX is used to treat epileptic seizures or fits on its own, or in combination with other medications. For more information, see Section 1. Why am I using ZEBINIX? in the full CMI. 2. WHAT SHOULD I KNOW BEFORE I USE ZEBINIX? Do not use if you are allergic to eslicarbazepine acetate, to other carboxamide derivatives or to any of the ingredients listed in Section 7. What ZEBINIX contains? in the full CMI. TALK TO YOUR DOCTOR IF YOU HAVE ANY OTHER MEDICAL CONDITIONS, TAKE ANY OTHER MEDICINES, OR ARE PREGNANT OR PLAN TO BECOME PREGNANT OR ARE BREASTFEEDING. For more information, see Section 2. What should I know before I use ZEBINIX? in the full CMI. 3. WHAT IF I AM TAKING OTHER MEDICINES? Some medicines may interfere with ZEBINIX and affect how it works. A list of these medicines is in Section 3. What if I am taking other medicines? in the full CMI. 4. HOW DO I USE ZEBINIX? • Use as directed by your doctor. Do not take more than the amount your doctor tells you to. • The tablets should be swallowed with a glass of water. • The tablets can be crushed, mixed with water or apple sauce, and all the dose shall be taken immediately. • You can take ZEBINIX with or without food. More instructions can be found in Section 4. How do I use ZEBINIX? in the full CMI. 5. WHAT SHOULD I KNOW WHILE USING ZEBINIX? THINGS YOU SHOULD DO • Remind any doctor, dentist or pharmacist you visit that you are using ZEBINIX • Call your doctor immediately if you feel very unwell, develop a rash, blistering, swelling or peeling on your skin/membranes, swallowing or breathing problems, suffer from confusion, worsening of seizures or d Lestu allt skjalið
▼ This medicinal product is subject to additional monitoring in Australia. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions at https://www.tga.gov.au/reporting-problems. AUSTRALIAN PRODUCT INFORMATION – ZEBINIX (ESLICARBAZEPINE ACETATE) TABLET 1 NAME OF THE MEDICINE Eslicarbazepine acetate 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ZEBINIX 200 mg tablet contains 200 mg of eslicarbazepine acetate. Each ZEBINIX 800 mg tablet contains 800 mg of eslicarbazepine acetate. For the full list of excipients, see Section 6.1 List of excipients. 3 PHARMACEUTICAL FORM Tablet. ZEBINIX 200 mg tablets are white oblong tablets, engraved with ‘ESL 200’ on one side and scored on the other side, with a length of 11 mm. The tablet can be divided into equal doses. ZEBINIX 800 mg tablets are white oblong tablets, engraved with ‘ESL 800’ on one side and scored on the other side, with a length of 19 mm. The tablet can be divided into equal doses. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS ZEBINIX is indicated as: • monotherapy in the treatment of partial-onset seizures, with or without secondary generalisation, in adults with newly diagnosed epilepsy; • adjunctive therapy in adults, adolescents and children aged above 6 years, with partial-onset seizures with or without secondary generalisation. Page 2 of 22 4.2 DOSE AND METHOD OF ADMINISTRATION DOSE _ADULTS _ _ _ ZEBINIX may be taken as monotherapy or added to existing anticonvulsant therapy. The recommended starting dose is 400 mg once daily which should be increased to 800 mg once daily after one or two weeks. Based on individual response, the dose may be increased to 1,200 mg once daily. Some patients on monotherapy regimen may benefit from a dose of 1,600 mg once daily (see Section 5.1 Pharmacodynamic properties). _PAEDIATRIC POPULATION _ _ _ _Children above 6 years of age: _ The recommended starting dose is 10 mg/kg/day once daily. Dosage should be increased in w Lestu allt skjalið